Processa Pharmaceuticals annual gross margin
2012
2013
2014
2015
2016
Processa Pharmaceuticals's gross margin was 100.00% for fiscal 2016.
View full Processa Pharmaceuticals company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2016 | 2016-12-31 | 100.00% | +110.98 pp |
| 2015 | 2015-12-31 | −10.98% | −48.66 pp |
| 2014 | 2014-12-31 | 37.68% | −2.16 pp |
| 2013 | 2013-12-31 | 39.84% | +9.19 pp |
| 2012 | 2012-12-31 | 30.65% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2016 | 2016-03-31 | 100.00% | +48.06 pp |
| Q3 2015 | 2015-09-30 | 26.73% | −11.06 pp |
| Q2 2015 | 2015-06-30 | 45.07% | −9.76 pp |
| Q1 2015 | 2015-03-31 | 33.88% | −17.75 pp |
| Q3 2014 | 2014-09-30 | 51.94% | +15.84 pp |
| Q2 2014 | 2014-06-30 | 37.79% | +1.04 pp |
| Q1 2014 | 2014-03-31 | 54.83% | +17.98 pp |
| Q4 2013 | 2013-12-31 | 51.63% | +20.77 pp |
| Q3 2013 | 2013-09-30 | 36.11% | −8.41 pp |
| Q2 2013 | 2013-06-30 | 36.75% | — |
| Q1 2013 | 2013-03-31 | 36.85% | — |
| Q3 2012 | 2012-09-30 | 30.87% | — |
| Q2 2012 | 2012-06-30 | 44.52% | — |
Across the available reported history, Processa Pharmaceuticals's gross margin increased from −10.98% to 100.00%, a change of +110.98 percentage points. The latest reported quarter, Q1 2016, shows 100.00%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Processa Pharmaceuticals filings at SEC.gov ↗